Improving the Outlook for Simultaneous Pancreas-Kidney Transplants
![](/media/12062702/peter-stock-md.jpg)
![](/media/1004346/ucsf_20191025_freise-chris_61-copy.jpeg)
UCSF Transplant Surgery - February 01, 2005
"The body's rejection of transplanted organs and tissues is an unfortunate risk of transplant surgery. Historically, rejection rates in a simultaneous pancreas-kidney (SPK) transplant have been as high as 80% and, in 2001, averaged nearly 20%. ........Diabetes Center surgeons Peter Stock, (left) and Chris Freise (right) have been pioneering new methods of immunosuppression for SPK transplants that do not rely upon steroids, with great success...... "